Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 9, 2010, Pages 2152-2163

  Chang, Jeffrey S ^a,b,c   Wiemels, Joseph L ^a   Chokkalingam, Anand P ^b   Metayer, Catherine ^b   Barcellos, Lisa F ^b   Hansen, Helen M ^a   Aldrich, Melinda C ^a   Guha, Neela ^b,d   Urayama, Kevin Y ^b,d   Scélo, Ghislaine ^d   Green, Janet ^b   May, Suzanne L ^b   Kiley, Vincent A ^e   Wiencke, John K ^a   Buffler, Patricia A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e Surgery Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADAPTIVE IMMUNITY; ALLELE; ARTICLE; CANCER RISK; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; HYPOTHESIS; IMMUNOGENETICS; IMMUNOMODULATION; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ADOLESCENT; CASE-CONTROL STUDIES; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77956502139     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0389     Document Type: Article

References (47)

1. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006;6:193-203. (Pubitemid 43292563)
2. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer 1995;71:1-5.
3. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60.
4. Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol 2001;30:1428-37. (Pubitemid 34134302)
5. Westergaard T, Andersen PK, Pedersen JB, et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997;89:939-47. (Pubitemid 27282066)
6. Ma X, Buffler PA, Selvin S, et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2002;86:1419-24. (Pubitemid 34548063)
7. Ma X, Buffler PA, Wiemels JL, et al. Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2005;14:1928-34. (Pubitemid 41161202)
8. Perrillat F, Clavel J, Auclerc MF, et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer 2002;86:1064-9. (Pubitemid 34438075)
9. Gilham C, Peto J, Simpson J, et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ 2005;330:1294. (Pubitemid 40813559)
10. Rosenbaum PF, Buck GM, Brecher ML. Early child-care and preschool experiences and the risk of childhood acute lymphoblastic leukemia. Am J Epidemiol 2000;152:1136-44.
11. Neglia JP, Linet MS, Shu XO, et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000;82:234-40.
12. Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol 2010;39:718-32.
13. Jourdan-Da Silva N, Perel Y, Mechinaud F, et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004;90:139-45. (Pubitemid 38174953)
14. McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 1999;80:1844-51. (Pubitemid 29389644)
15. MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault GP. Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study. Am J Epidemiol 2008;167:598-606. (Pubitemid 351323311)
16. Naumburg E, Bellocco R, Cnattingius S, Jonzon A, Ekbom A. Perinatal exposure to infection and risk of childhood leukemia. Med Pediatr Oncol 2002;38:391-7. (Pubitemid 34507282)
17. Cardwell CR, McKinney PA, Patterson CC, Murray LJ. Infections in early life and childhood leukaemia risk: a UK case-control study of general practitioner records. Br J Cancer 2008;99:1529-33.
18. Roman E, Simpson J, Ansell P, et al. Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 2007;165:496-504. (Pubitemid 46340551)
19. Nishi M, Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health 1989;43:352-5. (Pubitemid 20012856)
20. Petridou E, Trichopoulos D, Kalapothaki V, et al. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997;76:1241-7. (Pubitemid 27448025)
21. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Association of childhood leukaemia with factors related to the immune system. Br J Cancer 1999;80:585-90. (Pubitemid 29213217)
22. Wen W, Shu XO, Linet MS, et al. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 2000;11:303-7. (Pubitemid 30255872)
23. Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003;105:255-60.
24. Rosenbaum PF, Buck GM, Brecher ML. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol 2005;19:152-64.
25. Hughes AM, Lightfoot T, Simpson J, et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 2007;121:819-24.
26. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006;36:1357-66.
27. Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P. Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 2004;159:915-21.
28. Hansen HM, Wiemels JL, Wrensch M, Wiencke JK. DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev 2007;16:1686-90.
29. Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT. Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 2006;15:2533-6.
30. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
31. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
32. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
33. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 2006;34:D617-21.
34. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-47.
35. Sinnwell JP, Schaid DJ. Package "haplo stats." Available from: http://cran.r-project.org/ [accessed on September 15, 2009].
36. Liu N, Zhang K, Zhao H. Haplotype-association analysis. Adv Genet 2008;60:335-405.
37. Mathias RA, Gao P, Goldstein JL, et al. A graphical assessment of P values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet 2006;7:38.
38. Chakraborty R, Weiss KM. Frequencies of complex diseases in hybrid populations. Am J Phys Anthropol 1986;70:489-503.
39. Hanis CL, Chakraborty R, Ferrell RE, Schull WJ. Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am J Phys Anthropol 1986;70:433-41.
40. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-7.
41. + T lymphocytes into Th1/Th2 effectors. Vaccine 1998;16:1415-9.
42. Ribeiro-do-Couto LM, Boeije LC, Kroon JS, et al. High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur J Immunol 2001;31:3394-402.
43. Prescott SL, Macaubas C, Smallacombe T, et al. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy 1998;28 Suppl 5:39-44, discussion 50-1.
44. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology 2004;112:352-63.
45. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-46.
46. Pistiner M, Hunninghake GM, Soto-Quiros ME, et al. Polymorphisms in IL12A and cockroach allergy in children with asthma. Clin Mol Allergy 2008;6:6.
47. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-90.